Diabetes Flashcards
SE Metformin
GI»_space; swap to MR if not tolerated well
Lactic acidosis
SE Sulfonylureas
Gliclazide
Hypos
Increased appetite ,weight gain «_space;not preferred
SIADH secretion
Liver dysfunction (cholestatic)
Example of Sulfonylureas
Gliclazide
SE Glitazones
Weight gain Fluid retention Liver dysfunction Fractures CI: bladder cancer
SE Gliptins (DPP4I)
Pancreatitis
Exanatide
GLP1 agonist
Good for weight loss so patients >35 BMI – now used more often
SC injection
Who do you offer atorvastatin 20mg to?
T1DM + > 40 years of age > 10 years Established nephropathy Other CVD risk factors (such as obesity and hypertension)
T2DM >10% risk
Insulin sensitizer
Pioglitazone only one left
Acarbose
Glucosidase inhibitor, not really used now
Sulphonylurea MOA
Gliclazide
Inhibit potassium transporter in B cells> depolarisation »_space; insulin release
Hypo risk
When are sulphonylureas used?
Rapid reduction in Hba1c eg if > 100
Risk hypos so needs monitoring
Then later swap med
Biguanides
MOA
metformin
increase insulin sensitivity and glucose uptake
weight loss
reduces the risk of bowel/ breast/ brain/ prostate ca
Example of DPP4 I
liptins
linagliptin is renal ok, least interactions
DPP4 I MOA
Inhibits DPP4 from breaking down the incretins (GLP1 GIP) > increased incretins > stimulate insulin
Second line treatment
Metformin + DPP4 I SU SGLT 2 Pioglitazone